Engineered regulatory T cells that recognize birch pollen reduced allergic airway inflammation in mice, hinting at a future cell therapy for severe allergies.
Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.
Large reviews show that one to three cups of brewed coffee a day are linked with lower risks of liver disease, heart disease, stroke and Type 2 diabetes in most adults.
New structural variation sequencing reads long stretches of fetal DNA to pinpoint duplications, flips, and rearrangements, revealing which changes truly matter.
A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV vaccine may finally be possible.
South Carolina’s In Our DNA SC program brings free genomic screening to all 46 counties, uncovering hidden cancer and heart risks early enough to prevent serious illness.
Ten-year results show a single CAR T infusion can keep many patients with aggressive and slow-growing B-cell lymphomas cancer-free, pointing toward true long-term cures.
Dual long‑acting antibodies that lock RSV’s fusion protein from two sides protect against RSV A and B and prevent resistance, offering durable protection.
